Xwpharma

Xwpharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a global biotech with a pipeline of internally discovered novel small molecule drug candidates focused on neurological and neuropsychiatric disorders. *PLEASE NOTE, XW is NOT currently hiring. Someone is fraudulently offering work in our name.
Looking for a particular Xwpharma employee's phone or email?

Xwpharma Questions

News

Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative

Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders Quiver Quantitative

Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan

Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy Stock Titan

Avadel & XWPharma Unveil $2B+ Deal for Sleep Disorder Drug - NAVLIN DAILY

Avadel & XWPharma Unveil $2B+ Deal for Sleep Disorder Drug NAVLIN DAILY

Avadel Partners with XWPharma to Commercialize Sleep Medication - Pharmaceutical Executive

Avadel Partners with XWPharma to Commercialize Sleep Medication Pharmaceutical Executive

Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com

Avadel licenses once-at-bedtime oxybate therapy from XWPharma Investing.com

Avadel secures rights to develop valiloxybate globally - Pharmaceutical Technology

Avadel secures rights to develop valiloxybate globally Pharmaceutical Technology

The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review

The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH Sleep Review

Addressing unmet needs in treating a wide range of neurological disorders - Nature

Addressing unmet needs in treating a wide range of neurological disorders Nature

XWPharma takes in $40m series C round - - Global Venturing

XWPharma takes in $40m series C round - Global Venturing

Top Xwpharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant